Alexion Pharmaceuticals, Inc.
NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021
ALXN Articles
Here are three Credit Suisse #1 Top Picks that are showing an implied upside of 50% or more for 2020 as of mid-December.
Published:
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in...
Published:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in...
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Published:
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Last Updated:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
Last Updated:
Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Published:
Last Updated:
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations for Friday included AGCO, American Airlines, Bank of America, Beyond Meat, Ciena, DocuSign, Domo, Eloxx Pharmaceuticals, HCA Healthcare, Lululemon...
Published:
Last Updated:
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated: